Presence of recombinant interleukin 1 receptor antagonist distorts selective analyte detection in a commercial multiplex assay

Our findings highlight a significant and previously unrecognized source of error in multiplex cytokine assays involving a recombinant protein. We stress the importance of rigorous validation and awareness of potential reagent-matrix interactions to ensure robust and interpretable results in immunological studies.